You are here

  • Home
  • Archive
  • Volume 28, Issue 4
  • Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study

Citation Tools

Article menu
Download PDFPDF
Ovarian Cancer
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Selle F, Colombo N, Korach J, et al
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study
International Journal of Gynecologic Cancer 2018;28:729-737.